Phosphatidylserine trials recruiting now

1 registration that name phosphatidylserine as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 1 registration

Status

All 1 registrations

RecruitingNCT07710547

TCP-600 Supplementation and Performance Response in Professional Football Players

  • No phase
  • Vizja University in Warsaw
  • About 65 people
  • Starts Sep 2026 (estimated)

In plain words A study of phosphatidylserine in male participants 18 to 37, run by Vizja University in Warsaw. It plans to enroll about 65 people at 3 sites, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists male participants 18 to 37; healthy volunteers accepted. Conditions: Athletic Performance; Cognitive Fatigue; Exercise Recovery; Football-Specific Performance; Perceptual-cognitive Performance.

  • Male professional or highly trained football players aged 18-37 years.
  • Regular participation in structured football training and team activities.
  • Minimum of 5 years of structured football training experience.
  • Regular involvement in club training during the study period.

6 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Placebo; Taurine; Caffeine; Phosphatidylserine

Registered summary

This study will examine whether a 28-day supplementation protocol containing taurine, caffeine, and phosphatidylserine can help professional male football players maintain physical performance, cognitive function, recovery-related readiness, and selected football-specific perceptual-cognitive performance. Participants will be randomly assigned to receive either placebo or a phosphatidylserine-containing multi-ingredient supplement. The full summary is on the listing.

Where, as registered

No US site; Poland (3).

ClinicalTrials.gov lists 7 open registrations for this search, including ones where phosphatidylserine is not a study arm or that are past the 1 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.